Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Edesa Biotech, Inc. (EDSA) had Stock-Based Compensation of $0.54M for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-6.17M |
|
-- |
|
-- |
|
$7.01M |
|
$-7.01M |
|
$0.85M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
$-7.01M |
|
$-6.83M |
|
3.20M |
|
3.20M |
|
$-1.93 |
|
$-1.93 |
|
| Balance Sheet Financials | |
$1.68M |
|
-- |
|
$2.14M |
|
$3.81M |
|
$1.83M |
|
-- |
|
-- |
|
$1.83M |
|
$1.98M |
|
$-0.10M |
|
$1.98M |
|
3.25M |
|
| Cash Flow Statement Financials | |
$-4.89M |
|
-- |
|
$0.59M |
|
$5.36M |
|
$1.04M |
|
$-4.32M |
|
|
Stock-Based Compensation |
$0.54M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-311.44% |
|
6315.76% |
|
-161.77% |
|
-311.44% |
|
$0.61 |
|
$-1.53 |
|
$-1.53 |
|